Trends in Pharmaceutical Quality

What are the current trends in maintaining pharmaceutical quality? How are companies and regulators managing risks and incorporating patients? Sarah Pope Miksinski, PhD, Director, Division II, Office of New Drug Quality Assessment, OPS, CDER, and Roger Nosal, Vice President, CMC at Pfizer, discuss issues of Pharmaceutical Quality with Global Forum's Deputy Editor Alberto Grignolo.